Navigation Links
Lilly Reports Third-Quarter 2011 Results
Date:10/20/2011

>"In the third quarter Lilly continued to drive revenue growth for many key brands, including Cymbalta, Humalog, Forteo and Strattera, with strong growth also seen in animal health, Japan and China. This growth offset the continued erosion of Gemzar sales due to generic competition," said John C. Lechleiter, Ph.D., Lilly's chairman, president and chief executive officer. "As we face the loss of patent exclusivity for Zyprexa in most major markets, we are well-prepared as a company to meet the challenges before us. We remain committed to our innovation-based strategy and are focused on delivering the next wave of new medicines to patients in the coming years."

Key Events Over the Last Three Months

  • The European Commission granted marketing authorization for Trajenta® for the treatment of adults with type 2 diabetes. The company and its partner Boehringer Ingelheim have recently begun launching Trajenta in the European Union, beginning with the United Kingdom.

  • The U.S. Food and Drug Administration (FDA) approved Cialis® tablets for once daily use for the treatment of men who have both erectile dysfunction and the signs and symptoms of benign prostatic hyperplasia (ED+BPH). The FDA also approved Cialis for once daily use for a separate indication for the treatment of the signs and symptoms of BPH.

  • The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion for the use of Alimta® as continuation maintenance therapy in patients with advanced nonsquamous non-small cell lung cancer (NSCLC).

  • The U.S. Court of Appeals for the Federal Circuit overturned a prior ruling by the U.S. District Court for the District of New Jersey and upheld the validity of the company's method-of-use patent on Strattera®. The method-of-use patent provides protection for Strattera through May of 2017.

  • The company, along with its partners Amylin Pharmaceutic
    '/>"/>

  • SOURCE Eli Lilly and Company
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

    Related medicine technology :

    1. Lilly Declares Fourth-Quarter 2011 Dividend
    2. Lilly Announces Changes in Senior Management
    3. Lilly Confirms Date and Conference Call for Third-Quarter 2011 Financial Results Announcement
    4. Lilly Improves Its Environmental Footprint in Business Operations and Helps Beautify Communities
    5. Eli Lilly and Company Bringing Diabetes Education Program to the Annual Legislative Conference
    6. Lilly Celebrates 17th Consecutive Year as One of Working Mother 100 Best Companies
    7. Lilly Health Channel Debuts on YouTube
    8. Boehringer Ingelheim and Lilly to Feature Type 2 Diabetes Research in Presentations at the 47th Annual Meeting of the European Association for the Study of Diabetes
    9. The American Diabetes Association and Eli Lilly and Company Encourage African Americans to Learn About Diabetes Through a Familiar Face
    10. Lilly Announces Review of Data on Long-Term Raloxifene Treatment for Postmenopausal Osteoporosis Published in Current Medical Research & Opinion
    11. U.S. Court of Appeals Affirms Validity of Lillys Strattera Patent
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/26/2015)... -- Cellular testing for pharmaceuticals - how to ... of technologies for screening cells? Now discover those ... there for data, benefiting your influence. For those ... and revenue forecasts. That new report ... for cell-based assays and related applications ...
    (Date:5/26/2015)... , May 26, 2015 ... Initiative, Inc. (CHAI) announced today that Aurobindo Pharma has ... 50mg, for Tentative Approval, to the Food and Drug ... the first ANDA for a generic version of dolutegravir, ... (dolutegravir) for sale in the United States ...
    (Date:5/26/2015)... ALTO , Calif. and NEW YORK ... (NYSE: VAR ) and Flatiron Health ... develop the next generation of cloud-based, electronic health record ... care providers around the world. Together, the companies will ... a cloud-based integrated medical oncology, radiation oncology and data ...
    Breaking Medicine Technology:Cell-Based Assays: World Industry and Market Prospects 2015-2025 2Cell-Based Assays: World Industry and Market Prospects 2015-2025 3Cell-Based Assays: World Industry and Market Prospects 2015-2025 4Cell-Based Assays: World Industry and Market Prospects 2015-2025 5Cell-Based Assays: World Industry and Market Prospects 2015-2025 6Cell-Based Assays: World Industry and Market Prospects 2015-2025 7ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 2ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 3ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 4ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 5ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 6ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 7Varian Medical Systems and Flatiron Health to Develop Next Generation of Cloud-based Oncology Software 2Varian Medical Systems and Flatiron Health to Develop Next Generation of Cloud-based Oncology Software 3Varian Medical Systems and Flatiron Health to Develop Next Generation of Cloud-based Oncology Software 4
    ... , SEATTLE, Dec. 17 Amnis Corporation, a manufacturer ... will present at the 28th Annual J.P. Morgan Healthcare Conference. ... St. Francis Hotel in San Francisco. David Basiji, Ph.D., ... January 12 at 2:30 PM in Room F and will ...
    ... , OMAHA, Neb., Dec. 17 Transgenomic, Inc. (OTC ... agreement with Gene Solutions for an exclusive licensing option ... disease patients that can form the basis of a ... platform mitochondrial mutation detection technology will be evaluated and ...
    Cached Medicine Technology:Transgenomic, Inc. Executes License Option agreement for Parkinson's Disease Diagnostic Markers with Gene Solutions, LLC 2Transgenomic, Inc. Executes License Option agreement for Parkinson's Disease Diagnostic Markers with Gene Solutions, LLC 3Transgenomic, Inc. Executes License Option agreement for Parkinson's Disease Diagnostic Markers with Gene Solutions, LLC 4
    (Date:5/26/2015)... (PRWEB) May 26, 2015 Synthetic ... According to an article published by International ... marijuana (dubbed K2, Spice, and black mamba) causes ... of these synthetic substances make it nearly impossible ... patients’ use of the substance due to the ...
    (Date:5/26/2015)... (PRWEB) May 26, 2015 Indosoft, ... successful upgrade of the DMi Partners contact ... was the first in Indosoft's contact center ACD system ... added screen support for such trunk features as diversion ... lead management, and included upgrades to warm transfers ...
    (Date:5/26/2015)... Santa Rosa, CA (PRWEB) May 26, 2015 ... Management and Analytics solutions for more than 15 years, ... from the National Committee for Quality Assurance (NCQA) for ... today. , “We are proud of the work we ... years and are grateful for the acknowledgement from NCQA ...
    (Date:5/26/2015)... CA (PRWEB) May 26, 2015 ... protection since 1997, is excited to announce the launch ... first medical grade gloves made of polyethylene (PE) and ... examination and general applications. , The Enov8 ... in making sandwiches or mixing salads but our proprietary ...
    (Date:5/26/2015)... 26, 2015 The best and most ... already be in your pocket. That’s because Life Fitness, ... LFconnect mobile app to sync with the most popular ... and Samsung S-Health – automatically transmitting data collected directly ... now for download, empowers the millions of iPhone and ...
    Breaking Medicine News(10 mins):Health News:Synthetic Cannabinoids Can Cause Psychotic Episodes; Doctors at a Loss for Treatment 2Health News:Synthetic Cannabinoids Can Cause Psychotic Episodes; Doctors at a Loss for Treatment 3Health News:DMi Partners Upgrades to Indosoft Q-Suite 5.8 2Health News:DMi Partners Upgrades to Indosoft Q-Suite 5.8 3Health News:i2iTracks Earns NCQA 2014 PCMH Prevalidation 2Health News:i2iTracks Earns NCQA 2014 PCMH Prevalidation 3Health News:Enov8® Exam Glove by Adenna® Approved by U.S. FDA 2Health News:Life Fitness Expands Its Compatibility with Popular Fitness Apps 2Health News:Life Fitness Expands Its Compatibility with Popular Fitness Apps 3
    ... of Medicare recipients undergoing treatment for retinal conditions nearly ... the types of procedures most commonly performed, according to ... of Ophthalmology , one of the JAMA/Archives journals. ... both age-related macular degeneration (AMD) and diabetic retinopathy account ...
    ... symptoms associated with cancer symptoms often unrecognized ... of cancers regardless of whether the patient is ... survivor, according to researchers from the Regenstrief Institute ... nursing. Common symptoms include fatigue, pain, weakness, ...
    ... News) -- Women with epilepsy may be at increased risk of ... included 375 women who planned to have a child, average age ... to 10 years. During the study period, 62 percent of the ... epilepsy was more than twice the 15 percent rate in the ...
    ... By Steven Reinberg HealthDay Reporter , SUNDAY, Oct. ... to play a role in the propensity for obesity. ... the Oct. 10 online edition of Nature Genetics . ... gene variants linked to obesity and confirmed the involvement of ...
    ... the receipt of breast cancer care persist despite accounting ... is the conclusion of a study published early online ... American Cancer Society. The findings suggest that greater efforts ... care and to ensure that all affected women receive ...
    ... , UCSF Chancellor Susan Desmond-Hellmann, MD, MPH, will ... Arts and Sciences, alongside some of the world,s ... Desmond-Hellmann, a renowned oncologist and biotechnology ... biomedical research institution, was among five members of ...
    Cached Medicine News:Health News:Treatment of retinal conditions appears to have changed significantly in previous decade 2Health News:Physical symptoms prevalent no matter what stage of cancer including remission 2Health News:Study Sees Link Between Epilepsy, Infertility 2Health News:Researchers Pinpoint Array of Obesity Genes 2Health News:Researchers Pinpoint Array of Obesity Genes 3Health News:Insurance and socioeconomic status do not explain racial disparities in breast cancer care 2Health News:UCSF Chancellor inducted into Academy of Arts and Sciences 2Health News:UCSF Chancellor inducted into Academy of Arts and Sciences 3
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    Medicine Products: